30 results about "Oral Lozenge" patented technology

The invention discloses a functional food and medicine for clearing the throat and a preparation method thereof. The product comprises the following main materials in parts by weight: 14.5-43.5 parts of honeysuckle flower extract, 40.3-120.9 parts of fructus monordicae extract, 22.5-67.5 parts of chrysanthemum extract, 23.5-70.5 parts of boat-fruited sterculia seed extract and 2.5-7.5 parts of menthol, and auxiliary materials comprise sorbitol and magnesium stearate. The product is prepared into an oral lozenge by weighing, mixing, granulating, drying and tabletting. The product is prepared from the honeysuckle flower extract, the fructus momordicae extract, the chrysanthemum extract, the boat-fruited sterculia seed extract and the menthol as the main raw materials. The compatibility of the whole formula is researched and developed according to the traditional Chinese medicine theory and the modern pharmacology, the honeysuckle flower is used for clearing away heat and toxic material,the fructus momordicae is used for entering the lung and spleen and clearing away the lung heat and moistening dryness and expelling phlegm and arresting coughing, the chrysanthemum is matched for dispelling wind heat, the boat-fruited sterculia seed is used for clearing internal heat and relieving the throat, and the fresh sweet menthol is used for avoiding dirt and clearing away toxic material and clearing away the damp-heat from the throat, thereby forming a sweet and cool nourishing preparation for generating the effects of relieving and moistening the throat by synergism.

The present invention provides for compositions including nicotine salts, solutions thereof, methods of manufacture and methods of use. Certain embodiments provide for the delivery of the compositionsincluding by: transdermal, oral, nasal and inhalation modes. Certain embodiments provide nicotine salts and solutions thereof, suitable for or packaged in or with devices including: oral lozenges, chewing gum, transdermal patches, intranasal sprays and intranasal inhalers, e-liquids and e-cigarette or vaping devices.

The present invention relates to medicine, and is medicine for treating radioactive mucous membrane damage, recurrent aphtha and paradentitis. The medicine contains SOD, vitamin B12 and vitamin B2, and may be aerosol or oral lozenge. The aerosol product has the components of SOD 20000-100000 IU, vitamin B12 0.001-0.005 g and vitamin B2 0.005-0.015 g. The oral lozenge product has the components of SOD 1000-4000 IU, vitamin B12 0.000009-0.00009 g and vitamin B2 0.0002-0.0008 g. The medicine has wide material source, low cost, and other advantages.

The invention relates to anti-aging lozenges. The anti-aging lozenges are characterized by comprising components in percentage by mass as follows: 10%-25% of grape seed extract, 15%-35% of tea extract, 6%-12.5% of ganoderma lucidum, 5%-10% of largehead atractylodes rhizomes, 13%-20% of fructus lycii, 7%-16.5% of south dodder seeds and 1%-5% of syrup. According to the anti-aging lozenges, the grape seed extract and the tea extract are taken as active additives and added to the lozenges and have higher oxidation resistance and free radical scavenging capability; compared with other anti-aging agents, the composition can scavenge harmful free radicals and has an excellent ageing resistance function; the anti-aging lozenges are added with the ganoderma lucidum, the largehead atractylodes rhizomes, the fructus lycii and the south dodder seeds, contain multiple traditional Chinese medicine active ingredients and can promote metabolism of cells of a human body; the oral lozenges are prepared after the syrup is added, and the lozenges taste good during taking and are easily absorbed by the human body.

The present invention relates to health food, and especially a kind of health food containing emblic extract. The health food contains effective components comprising emblic extract in 20-99.98w and IgY in 0.02-80 wt%. The health food may be prepared into oral lozenge or beverage after adding proper amount of supplementary material. The health food of the present invention can raise the function of K+-Na+ pump in body's cell membrane to make energy source and bioactive matters enter to body fast, so as to promote the energy metabolism and inorganic matter metabolism, regulate water-electrolyte metabolism, resist anoxia and eliminating fatigue fast.

The invention discloses a rose-donkey-hide gelatin-Chinese yam oral buccal tablet and a preparation method thereof, and belongs to the field of rose processed foods. The rose-donkey-hide gelatin-Chinese yam oral buccal tablet is prepared from the following raw materials in parts by weight: 30-50 parts of a rose dried powder, 10-20 parts of a donkey-hide gelatin powder, 10-20 parts of a Chinese yam powder, 10-20 parts of a red jujube powder, 10-20 parts of a hawthorn powder, and 5-10 parts of honey. The technological process of the prepared rose-donkey-hide gelatin-Chinese yam oral buccal tablet adopts a physical way, various nutritional ingredients are not destroyed, the nutritional value is improved, moreover, the nutritional value is more comprehensive, and the role of food curative effect can be fully played; oxidation of anthocyanin in flowers of rosa rugosa cv.plena is also prevented, and the content of the anthocyanin in the rose-donkey-hide gelatin-Chinese yam oral buccal tablet is determined to be 105.56 mg / 100 g by Shandong academy of agricultural sciences.

The invention relates to a bactericide for being taken after swimming. The bactericide is prepared by the steps of grinding five medicaments into powder, and compressing the powder into an oral lozenge, wherein the five medicaments are as follows: 20-40 parts of radix scutellariae, 14-25 parts of fructus forsythia, 30-60 parts of ramulus cinnamomi, 15-30 parts of akebia stem and 20-35 parts of herba violae. The bactericide has relatively strong effects on the killing of main pathogenic bacteria in a swimming pool and is capable of effectively killing bacteria entering oral cavities and esophaguses.

The invention discloses a compound tetrastigma hemsleyanum pharyngitis lozenge and a preparation method thereof. The lozenge is prepared from a tetrastigma hemsleyanum extract powder prepared from the tetrastigma hemsleyanum with botrychium officinale and roots of imperata cylindrica, mannitol powder and aspartame as raw materials, with ethanol as a wetting agent and with addition of menthol and magnesium stearate. The oral lozenge is prepared through following steps: preparation of the extract powder, mixing of a filling agent, preparation of a soft material, granulation, a drying process, a granule reshaping process, a lozenge pressing process and a sterilizing and packaging process. The lozenge has a broad-spectrum antibacterial effect and a strong anti-respiratory syncytial virus and anti-influenza virus effect. In addition, the lozenge also has a certain inhibiting effect on staphylococcus aureus, pneumococcus, hemolytic streptococcus, shigella dysenteriae and the like. The lozenge can act on a disease location for a long period when being applied locally and a curative effect can be achieved maximumly. In addition, defects in orally-taking of traditional Chinese medicines and western medicines are overcome. The lozenge is sweet in taste, is refreshing in flavor, is good in mouthfeel and disintegration, is convenient to use, is easy to take and is suitable for people in various age.

The invention provides an oral slow release influenza vaccine and a preparation method thereof. The invention is a divisional application of Chinese patent application 200910103512X, comprises preparation methods for a whole virus inactivated vaccine, a cracking vaccine and a subunit vaccine and relates to a novel influenza oral lozenge or oral slow release vaccine preparation which is suitable to be orally taken and a preparation process thereof. The preparation method comprises preparation of a virus seed bank, production and preparation of vaccine stock solution, addition and freeze-dryingof a protectant and an excipient, composition of the oral lozenge or the oral slow release preparation, a forming process and the like. Through the oral influenza vaccine, pain and discomfort caused by injection can be avoided, a natural infection approach is simulated, the contact of most of mucous membrane surface region and the vaccine can be guaranteed, and immunological reaction of the mucous membrane and immunological reaction of a system are caused; the vaccine is not required to be produced under an extremely strict condition and is low in cost, and the cost required by increase in amount of required antigen can be relatively reduced; and the oral vaccine is convenient to use, is not required to be inoculated by a professional and is convenient to store and transport.

The invention provides a hemsley rockvine root lozenge for diminishing inflammation and resisting viruses and a preparation method thereof. The preparation method provided by the invention can be used for preparing a lozenge which keeps the original nutrient substance components and has the functions of diminishing inflammation and resisting viruses. The advanced technology is used for deeply processing the hemsley rockvine root, i.e. the hemsley rockvine root is treated by the processes of cleaning, crushing, microwave extraction, enzymatic saccharification, secondary filtration, spray drying, granulating, tabletting and the like, thus the hemsley rockvine root fully exerts the medical properties in the preparation process, and the effective components of the hemsley rockvine root are furthest protected. The Chinese herbal medicine hemsley rockvine root is prepared into an oral lozenge which can be carried simply, saved easily and taken conveniently and has the functions of diminishing inflammation and resisting viruses. The high-concentration medical lozenge can sterilize the oral throat and can enter a human body, so that the hemsley rockvine root can exert the functions of resisting bacteria, diminishing inflammation, resisting viruses and improving immunity. By orally taking the hemsley rockvine root lozenge for diminishing inflammation and resisting viruses, the bacteria in the oral cavity can be effectively sterilized, and upper respiratory tract communicable diseases such as influenza and the like can be prevented.

Extraction of cynanchum bunqei polysaccharide and preparation of its oral tablets pharmaceutics are achieved by: pulverizeing cynanchum bunqei (granular <4mm), Reflux extracting two to three times in 3-10 times alcohol . The extracted liquid is concentrated to recover for other uses. The extracted solid residues was extracted three times in certain ratio 1: 8-20 of materials and water at 80deg.C-100deg.C for 1-3 h, then incorporating the aquatic extracted liquid. The aquatic extracted liquid was concentrated, depositing with alcohol and drying to obtain cynanchum bunqei crude polysaccharide. The aquatic extracted liquid was destarch by enzyming, deproteinizing by chloroform- normal butanol method, depositing with alcohol and drying to get cynanchum bunqei total polysaccharide. The animal testing in vivo and testing in vitro prove that, the polysaccharide and total polysaccharide are capable of preparing pharmaceuticals as componets of immunoregulation fuctions and health-care food such as buccal tablets and oral liquid.

The present invention relates to medicine, and is medicine for treating radioactive mucous membrane damage, recurrent aphtha and paradentitis. The medicine contains SOD, vitamin B12 and vitamin B2, and may be aerosol or oral lozenge. The aerosol product has the components of SOD 20000-100000 IU, vitamin B12 0.001-0.005 g and vitamin B2 0.005-0.015 g. The oral lozenge product has the components of SOD 1000-4000 IU, vitamin B12 0.000009-0.00009 g and vitamin B2 0.0002-0.0008 g. The medicine has wide material source, low cost, and other advantages.

According to the SARS-CoV-2 yolk neutralizing antibody IgY spray for preventing and treating the new coronal pneumonia, the yolk neutralizing antibody IgY is a polyclonal antibody, comprises a new coronal virus S1 protein receptor binding domain antibody or a new coronal virus S2 protein antibody, and can block the binding of a new coronal virus and a cell receptor ACE2, neutralize the new coronal virus SARS-CoV-2, block the infection of the new coronal virus and inhibit and kill the virus; new crown pneumonia is prevented and treated; the S protein, the S1 protein, the RBD protein or the S2 protein of the new coronavirus is used as an antigen to immunize an egg laying hen, and the egg yolk antibody IgY is extracted from egg yolk. The invention provides an anti-new coronavirus yolk neutralizing antibody IgY preparation which can be a spray, an eye drop, an oral capsule or an oral lozenge. The action mode is safe, large-scale production is easy, immunological rejection is not generated, and a safe, simple, sanitary, effective and economical personalized epidemic prevention mode is created to deal with epidemic situations.

The present invention relates to plasmin producing strain and method of producing plasmin, and belongs to the field of food biotechnology. The present invention screens out one plasmin strain with thrombolysis capacity from fermented food shrimp paste, and the new strain is identified as one new variety of bacillus, and named as Bacillus sp.nov.SK006 and has the preservation number of CCTCC No. M205071. The present invention also provides method of producing plasmin with the said strain, and the method has less breeding work, low cost, high safety and reliability and may be used in large scale liquid fermentation production. The fermented product is non-toxic, and may be used in preparing capsule, granule, oral liquid or oral lozenge or as additive for health food or common food.

The invention discloses a functional food and medicine for clearing the throat and a preparation method thereof. The product comprises the following main materials in parts by weight: 14.5-43.5 parts of honeysuckle flower extract, 40.3-120.9 parts of fructus monordicae extract, 22.5-67.5 parts of chrysanthemum extract, 23.5-70.5 parts of boat-fruited sterculia seed extract and 2.5-7.5 parts of menthol, and auxiliary materials comprise sorbitol and magnesium stearate. The product is prepared into an oral lozenge by weighing, mixing, granulating, drying and tabletting. The product is prepared from the honeysuckle flower extract, the fructus momordicae extract, the chrysanthemum extract, the boat-fruited sterculia seed extract and the menthol as the main raw materials. The compatibility of the whole formula is researched and developed according to the traditional Chinese medicine theory and the modern pharmacology, the honeysuckle flower is used for clearing away heat and toxic material,the fructus momordicae is used for entering the lung and spleen and clearing away the lung heat and moistening dryness and expelling phlegm and arresting coughing, the chrysanthemum is matched for dispelling wind heat, the boat-fruited sterculia seed is used for clearing internal heat and relieving the throat, and the fresh sweet menthol is used for avoiding dirt and clearing away toxic material and clearing away the damp-heat from the throat, thereby forming a sweet and cool nourishing preparation for generating the effects of relieving and moistening the throat by synergism.